Anthony S. Kim

Anthony S. Kim

Auto-generated profile, based on publicly available information

Anthony S. Kim

Department of Neurology (W.S.S., N.K., A.S.K., C.H., S.A.J.), University of California, San Francisco

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2011 in Circulation
Verified
Journal Article
Open access
PDF file
AKAnthony S. Kim
Anthony S. Kim
SJS. Claiborne Johnston
S. Claiborne Johnston
Background—: Although stroke and ischemic heart disease (IHD) have several well-established risk factors in common, the extent of global variation in the relative burdens of these forms of vascular disease and reasons for any observed variation are poorly understood. Methods and Results—: We analyzed mortality and disability-adjusted life-year loss rates from stroke and IHD, as well as national estimates of vascular risk factors that have been developed by the World Health Organization Burden of Disease Program. National income data were derived from World Bank estimates. We used linear regression for univariable analysis and the Cuzick test for trends. Among 192 World Health Organization member countries, stroke mortality rates exceeded IHD rates in 74 countries (39%), and stroke disability-adjusted life-year loss rates exceeded IHD rates in 62 countries (32%). Stroke mortality ranged from 12.7% higher to 27.2% lower than IHD, and stroke disability-adjusted life-year loss rates ranged from 6.2% higher to 10.2% lower than IHD. Stroke burden was disproportionately higher in China, Africa, and South America, whereas IHD burden was higher in the Middle East, North America, Australia, and much of Europe. Lower national income was associated with higher relative mortality ( P <0.001) and burden of disease ( P =0.001) from stroke. Diabetes mellitus prevalence and mean serum cholesterol were each associated with greater relative burdens from IHD even after adjustment for national income. Conclusions—: There is substantial global variation in the relative burden of stroke compared with IHD. The disproportionate burden from stroke for many lower-income countries suggests that distinct interventions may be required.

22 April 2015 in The Neurohospitalist
Verified
Journal Article
Closed access
NCNatalie T. Cheng
Natalie T. Cheng
AKAnthony S. Kim
Anthony S. Kim
Data from randomized clinical trials have supported the safety and efficacy of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke when administered within 3 hours of symptom onset, and regulatory approvals for this indication have been in place for almost 20 years. However, recent clinical trials have provided evidence that IV tPA may be safe and effective in selected patients up to 4.5 hours after symptom onset, thereby increasing the proportion of patients that may be eligible for treatment. Although professional organizations in the United States and many regulatory agencies internationally have supported this expanded time window for IV tPA, the US Food and Drug Administration has declined to approve this expanded indication and so this use of IV tPA has remained off-label in the United States. Here we review the current evidence for IV tPA in the standard and the expanded time windows and the data on current clinical practice in the United States as it relates to IV tPA treatment for acute stroke within 3 to 4.5 hours of symptom onset.

1 December 2015 in Stroke
Verified
Journal Article
Open access
PDF file
AKAnthony S. Kim
Anthony S. Kim
ECElizabeth Cahill
Elizabeth Cahill
NCNatalie T. Cheng
Natalie T. Cheng
Over the past several decades, much of the developed world has experienced a sustained reduction in age-standardized stroke mortality and morbidity rates.1 For many of these countries, these improvements have translated into declines in absolute stroke mortality and morbidity as well. For example, stroke had been the third-leading cause of death in the United States for >70 years until 2008, when it became the fourth leading cause of death.2,3 Just 5 years later, stroke became the fifth leading cause of death4—a drop that reflected the >60% decline in the age-adjusted mortality rate from stroke over just the past few decades.5,6 For most other developed countries, the recent experience and outlook for stroke has been similar.1,7 Over the past 20 years, high-income countries as a group have experienced a 13% decline (95% confidence interval, 6–18%) in the age-standardized incidence rate, a 37% decline (95% confidence interval 19–39%) in the age-standardized mortality rate, and a 21% decline (95% confidence interval, 10–27%) in the age-standardized disease burden from ischemic stroke as measured in disability-adjusted life year (DALY) loss rates.8,9 (DALYs are a summary measure of disease burden that combines the impact of years of healthy life lost caused by premature death with the effect of long-term disability on quality of life over time.) For hemorrhagic stroke, there have been similar improvements in these indicators over the same period.8,10 However, the global outlook for the total disease burden from stroke is a bit more humbling. In 2013, an estimated 6.4 million deaths (11.8% of all deaths) were caused by stroke, and stroke remained the third-leading cause of years-of-potential-life lost worldwide (Table 1).1,8,11,12 Between 1990 and 2010, the absolute incidence of …

1 November 2012 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
BNBabak B. Navi
Babak B. Navi
HKHooman Kamel
Hooman Kamel
MSMaulik P. Shah
Maulik P. Shah
AGAaron W. Grossman
Aaron W. Grossman
CWChristine Wong
Christine Wong
AKAnthony S. Kim
Anthony S. Kim

1 January 2011 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
AKAnthony S. Kim
Anthony S. Kim
HFHeather J. Fullerton
Heather J. Fullerton
SJS. Claiborne Johnston
S. Claiborne Johnston

1 June 2012 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
AKAnthony S. Kim
Anthony S. Kim
SSStephen Sidney
Stephen Sidney
JKJeffrey G. Klingman
Jeffrey G. Klingman
SJS. Claiborne Johnston
S. Claiborne Johnston